Literature DB >> 16239288

Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.

Laura Briñas1, Marta Lantero, Isabel de Diego, María Alvarez, Myriam Zarazaga, Carmen Torres.   

Abstract

OBJECTIVES: To characterize the beta-lactamase genes of the expanded-spectrum cephalosporin-resistant Escherichia coli isolates recovered in a Spanish hospital during the March 2002-March 2003 period.
METHODS: Thirty-four of the 1700 E. coli isolates recovered from unrelated patients in a Spanish hospital showed expanded-spectrum cephalosporin resistance. The presence of genes encoding TEM, SHV, CTX-M, CMY-2-type or FOX beta-lactamases as well as the existence of mutations in the regulatory region of the chromosomal ampC gene were studied by PCR and sequencing in these 34 E. coli isolates.
RESULTS: The following extended-spectrum beta-lactamases (ESBLs) or plasmidic class C beta-lactamase genes were detected (number of isolates): bla(CTX-M-14) (14), bla(CTX-M-9) (4), bla(CTX-M-32) (1), bla(TEM-52) (2), bla(SHV-12) (3) and bla(CMY-2) (2). The remaining eight isolates showed a mutation in the promoter/attenuator region of the ampC chromosomal gene at position -42, in combination with mutations at positions -18, -1 and +58. The bla(TEM-1) gene was also detected in 12 of the ESBL-producing isolates, in both CMY-2-producing isolates and in four of the eight isolates that showed a mutation at position -42 of the ampC promoter. Other mutations in the promoter/attenuator region were detected in association with ESBL or CMY-2 genes, such as the combination -18, -1 and +58, -28 and +58, or +22, +26, +27 and +32. No clonal relationship was found among the CTX-M-producing E. coli isolates by PFGE with XbaI enzyme.
CONCLUSIONS: Approximately 1.5% of the E. coli isolates of our hospital harboured ESBL genes, those of the CTX-M-9 group being the most common ones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239288     DOI: 10.1093/jac/dki370

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Recombination and selection can remove blaTEM alleles from bacterial populations.

Authors:  Joanna E Mroczkowska; Miriam Barlow
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

2.  Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.

Authors:  Bashar W Shaheen; Rajesh Nayak; Steven L Foley; Ohgew Kweon; Joanna Deck; Miseon Park; Fatemeh Rafii; Dawn M Boothe
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

3.  Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.

Authors:  S Peter-Getzlaff; S Polsfuss; M Poledica; M Hombach; J Giger; E C Böttger; R Zbinden; G V Bloemberg
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

4.  Genotypic-phenotypic discrepancies between antibiotic resistance characteristics of Escherichia coli isolates from calves in management settings with high and low antibiotic use.

Authors:  Margaret A Davis; Thomas E Besser; Lisa H Orfe; Katherine N K Baker; Amelia S Lanier; Shira L Broschat; Daniel New; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

5.  Fitness trade-offs in blaTEM evolution.

Authors:  Joanna E Mroczkowska; Miriam Barlow
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

6.  AmpC promoter and attenuator mutations affect function of three Escherichia coli strains.

Authors:  Wang Yu; Liu Bing; Li Zhenhua
Journal:  Curr Microbiol       Date:  2009-05-30       Impact factor: 2.188

7.  Diversity of extended-spectrum beta-lactamases and class C beta-lactamases among cloacal Escherichia coli Isolates in Belgian broiler farms.

Authors:  Annemieke Smet; An Martel; Davy Persoons; Jeroen Dewulf; Marc Heyndrickx; Boudewijn Catry; Lieve Herman; Freddy Haesebrouck; Patrick Butaye
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

8.  Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.

Authors:  Johann D D Pitout; Daniel B Gregson; Deirdre L Church; Kevin B Laupland
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

9.  High rate of mobilization for blaCTX-Ms.

Authors:  Miriam Barlow; Rebecca A Reik; Stephen D Jacobs; Mónica Medina; Matthew P Meyer; John E McGowan; Fred C Tenover
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

10.  Detection of ESBL- and AmpC-producing E. coli isolates from urinary tract infections.

Authors:  Sara Shayan; Mohammad Bokaeian
Journal:  Adv Biomed Res       Date:  2015-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.